Abstract
Abstract
Objectives
This study aims to gain insight into each attribute as presented in the value of implantable medical devices, quantify attributes’ strength and their relative importance, and identify the determinants of stakeholders’ preferences.
Methods
A mixed-methods design was used to identify attributes and levels reflecting stakeholders’ preference toward the value of implantable medical devices. This design combined literature reviewing, expert’s consultation, one-on-one interactions with stakeholders, and a pilot testing. Based on the design, six attributes and their levels were settled. Among 144 hypothetical profiles, 30 optimal choice sets were developed, and healthcare professionals (decision-makers, health technology assessment experts, hospital administrators, medical doctors) and patients as stakeholders in China were surveyed. A total of 134 respondents participated in the survey. Results were analyzed by mixed logit model and conditional logit model.
Results
The results of the mixed logit model showed that all the six attributes had a significant impact on respondents’ choices on implantable medical devices. Respondents were willing to pay the highest for medical devices that provided improvements in clinical safety, followed by increased clinical effectiveness, technology for treating severe diseases, improved implement capacity, and innovative technology (without substitutes).
Conclusions
The findings of DCE will improve the current evaluation on the value of implantable medical devices in China and provide decision-makers with the relative importance of the criteria in pricing and reimbursement decision-making of implantable medical devices.
Publisher
Cambridge University Press (CUP)
Reference24 articles.
1. Eliciting preferences for medical devices in South Korea: A discrete choice experiment;Lee;Health Policy.,2017
2. 21. National Medical Product Administration. The First BOao International Pharmaceutical and Mecial Devices Real-world Research Conference. 2022. Available from: https://www.nmpa.gov.cn/yaowen/ypjgyw/hyxx/20221208194613172.html (accessed August 10, 2023).
3. Discrete choice experiments in health economics: A review of the literature;de Bekker-Grob;Health Econ.,2012
4. 4. National Healthcare Security Administration. The National Medical Insurance Bureau officially launched the three-year action plan for DRG/DIP payment reform. 2021. Available from: http://www.nhsa.gov.cn/art/2021/11/26/art_104_7413.html (accessed August 10, 2023).
5. Establishment of multi-criteria value assessment index system for medical consumables;Huangying;China Health Insur.,2021